Alexandra Karadimou
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Co-authors
- Stéphane OudardWolf H. FridmanMeletios Α. DimopoulosBenoit BeuselinckAristotelis BamiasJessica Zucman‐RossiHélène PéréAlain Tedgui
- Topics
- Renal cell carcinoma treatment (14 papers)Renal and related cancers (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaClinical Cancer Research
In The Last Decade
Alexandra Karadimou
26 papers receiving 936 citations
Peers
Comparison fields: 5 of 81
- Oncology 479
- Pulmonary and Respiratory Medicine 464
- Molecular Biology 353
- Cancer Research 225
- Immunology 190
Countries citing papers authored by Alexandra Karadimou
This map shows the geographic impact of Alexandra Karadimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Karadimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Karadimou more than expected).
Fields of papers citing papers by Alexandra Karadimou
This network shows the impact of papers produced by Alexandra Karadimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Karadimou. The network helps show where Alexandra Karadimou may publish in the future.
Co-authorship network of co-authors of Alexandra Karadimou
This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Karadimou. A scholar is included among the top collaborators of Alexandra Karadimou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Karadimou. Alexandra Karadimou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | 230 | |
| 4 | 19 | |
| 5 | 27 | |
| 6 | 0 | |
| 7 | 70 | |
| 8 | 3 | |
| 9 | 86 | |
| 10 | 66 | |
| 11 | 6 | |
| 12 | 0 | |
| 13 | 17 | |
| 14 | 249 | |
| 15 | 13 | |
| 16 | 24 | |
| 17 | 14 | |
| 18 | 24 | |
| 19 | 45 | |
| 20 | 9 |
About Alexandra Karadimou
Alexandra Karadimou is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 28 papers that have together received 959 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Renal and related cancers (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (479 citations), Cancer Research (225 citations) and Pulmonary and Respiratory Medicine (464 citations). Alexandra Karadimou has collaborated with scholars based in Greece, France and Belgium. Frequent co-authors include Stéphane Oudard, Wolf H. Fridman, Meletios Α. Dimopoulos, Benoit Beuselinck, Aristotelis Bamias, Jessica Zucman‐Rossi, Hélène Péré, Alain Tedgui, Julien Taı̈eb and Cécile Badoual. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.